Healthcare -
Biotechnology - NASDAQ - US
$ 5.31
-0.562 %
$ 165 M
Market Cap
-2.0
P/E
ACRV - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ACRV - Acrivon Therapeutics, Inc. Common Stock
50.7 M
LAST VALUE
1366.62%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR